NEWS
Early warning device completes clinical pilot
A device designed to identify infection in dialysis patients has completed a successful pilot clinical investigation, following a funding award from Health Innovation Manchester. Manchester-based medical device company Microbiosensor, secured £50,000 from the Energise Innovation Fund in 2016 to pilot its PD Safe device in Manchester.
The PD Safe is aimed at those on peritoneal dialysis therapy (PD) and acts as an early warning system for peritonitis, an infection that can prove fatal if left untreated. Less than 10% of patients on renal replacement therapy are on PD, with an average therapy duration of only five years. Recurrent infections are a major cause of technique failure of PD and current best practice relies on patient’s self-reporting possible symptoms of infection– abdominal pain, fever and visually checking a clear plastic waste bag for signs of cloudiness in their PD waste. However, as the symptoms are not specific and not detectable until an infection has become well-established, patients can find making a judgement stressful and difficult - leading to a delay in time to diagnosis and treatment. The PD Safe is designed to overcome this issue by plugging into existing PD waste fluid tubing and flagging an emerging infection at a pre-symptomatic stage via a simple colour change in a readout window.
The device uses a small dialysis waste sample from the patient to fill a series of reaction chambers containing chemicals which can detect bacteria and provide a rapid, clear colour change to alert the user to the infection.
Following the funding award,
Microbiosensor has completed a successful pilot clinical investigation of the PD Safe device at the Manchester Royal Infirmary renal centre, working with consultant nephrologist Dr Anand Vardhan at the PD clinic.
The device successfully acted as an early warning system for infection, detecting bacteria within samples from patients, including one who was admitted to A&E within a few days as they went on to develop peritonitis. Ben Bridgewater, CEO of Health Innovation Manchester, said: “The PD-Safe device is an excellent example of the solutions Health Innovation Manchester aims to support in their journey to market. “The successful pilot clinical investigation in Greater Manchester marks a great leap forward in the project which has the potential to meet the needs of local people and patients. “It is vital that products like the PD-Safe are given support in order to transform health and social care and Health Innovation Manchester is uniquely placed to champion these innovations and connect researches, academics, business and the NHS in Greater Manchester.”
Complete decontamination systems
UK Autoclave manufacturer LTE Scientific has teamed up with European washer-disinfector manufacturer KEN Hygiene to offer a complete decontamination system for UK sterile services departments. LTE offers its Touchclave Systems porous load steam sterilisers in sizes ranging from 15ft3
to 42ft3 , and both
single entry and pass-through variants. All models can be configured to run on conventional or clean steam supplies, and LTE can provide a range of steam generators and heat exchangers. All LTE sterilisers are designed to use minimal energy and water, while delivering fast cycle times – in many cases less than 45 minutes. LTE can also supply a range of manual, semi-automatic and fully automatic loading/unloading systems, which in many cases can also be retro- fitted to LTE and other brands of autoclave. Semi-automatic and automatic unloaders are designed to provide advantages in terms of manual handling and health and safety. KEN Hygiene, based in Denmark, is one of Europe’s leading washer disinfector manufacturers, and has launched its new touchscreen IQ5 and IQ6 range, with loading capacities from 10-18DIN. The IQ range features low energy and water usage, and fast cycle times.
JUNE 2018
WWW.CLINICALSERVICESJOURNAL.COM I 11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80
